from Reuters: Top News http://uk.reuters.com/article/uk-samsung-biologics-ipo-idUKKCN12404Z?feedType=RSS&feedName=topNews
Tuesday, 4 October 2016
Samsung BioLogics may raise $2 billion in South Korea's third-biggest IPO
SEOUL (Reuters) - Samsung BioLogics Co Ltd, a contract manufacturer of biotech drugs for global pharmaceutical firms, said on Tuesday its initial public raising could raise up to $2 billion (1.57 billion pounds) in an offering set to be the country's third-largest IPO.
from Reuters: Top News http://uk.reuters.com/article/uk-samsung-biologics-ipo-idUKKCN12404Z?feedType=RSS&feedName=topNews
from Reuters: Top News http://uk.reuters.com/article/uk-samsung-biologics-ipo-idUKKCN12404Z?feedType=RSS&feedName=topNews
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment